Topic: FDA

Patient Access or Industry Excess?

Patient Access or Industry Excess?

Ethical and policy considerations of the 21st Century Cures Act

by Jeffrey Gruenglas

Issue: Autumn 2017

Topics: 21st Century Cures Act, FDA, Drug Access, Drug Approval